Cannabis Industry News

Let me search for more specific recent market data and statistics:

For great deals today, check out https://amzn.to/44ci4hQ

This content was created in partnership and with the help of Artificial Intelligence AI

CANNABIS INDUSTRY UPDATE - DECEMBER 3-4, 2025

Over the past 48 hours, the cannabis sector has experienced significant regulatory developments and strategic business movements.

REGULATORY SHIFTS

The Supreme Court scheduled a closed-door meeting for December 12, 2025, to consider whether to take up a landmark case challenging federal marijuana prohibition. State-legal cannabis businesses backed by Boies Schiller Flexner LLP argue that continued federal enforcement violates the Commerce Clause. This represents a potential watershed moment for federal cannabis policy.

Meanwhile, regulatory changes are reshaping state markets. Texas finalized new medical marijuana rules effective immediately, expanding qualifying conditions...

Cannabis Industry Update: Past 48 Hours

The cannabis sector has experienced significant developments over the past two days, marked by strategic consolidation, regulatory shifts, and record-breaking consumer activity.

Market Performance and Stock Movements

Cannabis stocks faced substantial pressure this week. Tilray plunged 16 percent after announcing a 1-for-10 reverse stock split aimed at attracting institutional investors. Other major operators showed weakness as well, with Canopy Growth sliding to 1.14 dollars, Aurora Cannabis holding around 4.54 dollars, and Cronos Group remaining flat near 2.47 dollars. Investors remain cautious amid regulatory uncertainty and sector challenges.

Strategic Partnerships Expand Global...

CANNABIS INDUSTRY STATE ANALYSIS: DECEMBER 1-2, 2025

Virginia's legislature is poised to finalize a comprehensive cannabis retail framework after months of deliberation. The Joint Commission on the Future of Cannabis Sales unveiled a revised proposal on December 1st that eliminates controversial local opt-out provisions while expanding local taxing authority. Commission Chair Paul Krizek emphasized the goal of creating a decentralized market prioritizing small, independent Virginia-based businesses over large medical operators. Up to 50 percent of initial licenses will be reserved for micro-businesses, with all license holders capped at five total retail and processing authorizations. This structure aims to channel tax...

The cannabis industry is facing a major shakeup following the recent federal crackdown on hemp products. Just this week, the new Continuing Appropriations and Extensions Act, signed into law on November 12, 2025, has fundamentally changed the legal landscape for hemp. The law limits THC in edible and beverage products to just 0.4 milligrams, which industry experts say will effectively ban over 95 percent of hemp products currently on the market. This is a sharp reversal from the 2018 Farm Bill, which had opened up opportunities for hemp-based businesses.

Major companies like Tilray Brands are feeling the impact. Tilray, which has positioned itself...

CANNABIS INDUSTRY UPDATE: NOVEMBER 26-28, 2025

The cannabis industry continues its strategic expansion phase with several notable developments emerging over the past 48 hours. The Cannabist Company has expanded its Old Pal partnership into West Virginia, marking the brand's fifth market through this collaboration. This expansion follows successful launches in Maryland, Virginia, New Jersey, and Colorado, demonstrating continued confidence in regional market penetration strategies focused on consistency and value positioning.

On the regulatory front, significant legislative momentum has developed around hemp product definitions. Senate Bill 56 in Ohio advanced through the legislative conference committee with revisions, while federal hemp...

CANNABIS INDUSTRY STATE ANALYSIS: NOVEMBER 25-27, 2025

The cannabis industry experienced significant regulatory and commercial momentum over the past 48 hours, with multiple developments reshaping market dynamics.

REGULATORY DEVELOPMENTS

The U.S. Supreme Court scheduled a closed-door meeting for December to discuss a case filed by marijuana businesses seeking to overturn federal prohibition, marking a potentially pivotal moment for industry legalization efforts. Meanwhile, congressional banking legislation remains stalled, with Senator Jeff Merkley describing cannabis industry banking advancement as "on the back burner," indicating legislative progress has significantly slowed.

New York Governor Kathy Hochul signed...

The cannabis industry has faced a dramatic shift over the past 48 hours, triggered largely by new federal legislative action in the United States. Congress recently passed the FY26 Agriculture Appropriations Bill, which redefines hemp and sharply restricts cannabinoids by banning products with more than 0.4 milligrams of THC per container. This regulatory move has sent shockwaves through the CBD and hemp markets. Industry groups warn that 95 percent of current hemp extract products may now be classified as Schedule I narcotics if Congress does not revise the law, potentially leaving millions of dollars in unsold inventory and forcing many businesses to the...

The global cannabis industry has experienced notable turbulence and transformation in the past 48 hours, driven by regulatory changes, market moves, and shifting industry partnerships. In the United States, federal action is at the forefront: A spending package signed by former President Trump is set to ban most consumable hemp products starting in November 2026, sparking pushback from hemp advocates and new legal disputes. Major cases like CannaProvisions’ challenge to federal marijuana prohibition and the Supreme Court’s upcoming review of gun rights for cannabis users signal rising legal scrutiny and potential shifts in industry risks. Ohio and Massachusetts are reconsidering state-level reta...

Over the past 48 hours, the cannabis industry has experienced both expansion and mounting challenges across global markets. Several leading firms announced significant moves designed to strengthen international reach, bolster research pipelines, and respond to rapidly evolving consumer trends.

Canopy Growth expanded its medical cannabis product range in Australia with the launch of new softgel capsules. This move underlines their commitment to international medical markets and aims to offer more convenient dosing options for patients. Canopy Growth’s strategic attention to Australia reflects increased demand for diversified medical cannabis formats.

Decibel Cannabis reported a 2621 percent year-over-year surge in...

The cannabis industry has experienced major developments in the past 48 hours, marked by new regulations, product launches, partnerships, and market shifts.

A significant regulatory move occurred as Congress included a ban on many hemp-derived THC products within its recent government funding legislation. This action, finalized November 19, directly impacts products such as low-dose hemp-derived THC and sets the stage for these products to be regulated similarly to alcohol moving forward. Industry leaders state they remain committed to finding a sensible framework to preserve access to natural hemp-derived products like full-spectrum CBD, but uncertainty is prompting hemp-based companies to consider...

The cannabis industry has undergone dramatic shifts in the past 48 hours, as new federal legislation has effectively upended the playing field for both hemp and cannabis operators. Last week, Congress quietly inserted a sweeping cap of 0.4 milligrams total THC per serving in hemp-derived products into a federal funding bill. This single provision puts nearly all intoxicating cannabinoids, such as Delta-8 and THC-infused seltzers and edibles, on a path to being banned, jeopardizing up to 95 percent of the 28 billion dollar hemp market and an estimated 300,000 jobs. While the new rules will not take full effect until late 2026, consumer and business anxiety...

In the past 48 hours, the cannabis industry has been rocked by major regulatory developments and renewed market uncertainty. The United States Congress acted to close the hemp-derived THC loophole, a move that redefines hemp at the federal level and will, in 365 days, render many current hemp-derived cannabinoid products federally controlled substances. This affects the widespread sale of psychoactive hemp-infused beverages and edibles, which have become popular through mainstream alcohol retailers. Industry observers predict this will dry up investor interest and force many hemp businesses to pivot or wind down operations. The news follows months of speculation after the 2018 Farm Bill’s...

In the past 48 hours, the cannabis industry has faced major regulatory, market, and supply chain disruptions in both the U.S. and internationally. The U.S. Congress is advancing a spending bill that proposes a near-total ban on hemp-derived THC products by lowering the allowable THC limit to 0.4 milligrams. Industry sources report that this change could make about 99 percent of current hemp inventory illegal, threatening to effectively shut down the 28 billion dollar hemp sector. Store owners, growers, and medical cannabis patients are raising alarms about the potential impact, which could force closures and spark a supply chain crisis across states...

Over the past 48 hours, the cannabis industry has faced significant disruption and rapid change at both national and global levels. The most notable development is the passage of a federal spending bill by the U.S. Senate proposing a ban on hemp-derived THC products by lowering the allowable THC limit to 0.4 milligrams. Industry sources estimate this measure could effectively illegalize up to 99 percent of existing hemp inventory, jeopardizing a nearly 28 billion dollar sector and leaving hemp businesses scrambling to overhaul product lines or exit the market.

At the same time, industry leaders are striking new strategic partnerships to...

Over the past 48 hours, the cannabis industry has faced a major regulatory disruption as Congress advanced a government spending deal that includes a near-total ban on hemp-derived THC products. The legislation, which President Trump supports, would redefine legal hemp to impose a strict 0.4 milligram cap on total THC per container and ban all synthetic or chemically modified cannabinoids. This move effectively outlaws popular products like delta-8 and delta-10 THC, as well as most low-dose THC beverages, which have relied on loopholes in the 2018 Farm Bill. The new rules are expected to collapse the multi-billion dollar gray market for intoxicating hemp...

The global cannabis industry is undergoing a period of accelerated change driven by regulatory actions, renewed investment, and evolving consumer demand. In the United States Senate, a major spending bill advanced this weekend includes a landmark provision that would drastically tighten federal regulations on hemp-derived THC products. If passed, the bill would cap total THC content at just 0.4 milligrams per product, effectively outlawing most products currently available under the 2018 Farm Bill and prompting market-wide uncertainty as businesses and consumers await a final decision from the House of Representatives and President Trump. This move would significantly disrupt the growing market for...

The cannabis industry has entered November 2025 in a period of cautious adjustment, marked by regulatory uncertainty, price pressure, and continued innovation. Over the past 48 hours, two prominent developments have shaped the landscape: regulatory activity and shifting financial performance at major operators.

At the federal level, former White House staffers have recently discussed cannabis rescheduling and the mass pardons process, signaling Congress’s ongoing focus on marijuana policy. Meanwhile, the Supreme Court delayed a key marijuana and gun rights case, keeping industry stakeholders in a holding pattern regarding federal legal clarity. States remain active battlegrounds, with Massachusetts advancing a ca...

In the past 48 hours, the cannabis industry has faced a turbulent mix of expansion, regulatory uncertainty, and labor milestones. Markets have been challenged by an ongoing debate over hemp-derived THC beverages, as major alcohol industry players lobby to remove these products from shelves. This is creating notable tension in the fast-growing segment of hemp-infused drinks, with MariMed responding by launching new hemp-derived THC products in Rhode Island and planning to expand nationwide. MariMed stock dropped almost 9 percent in the last week, signaling investor caution around these new product strategies and the broader regulatory environment.

On the corporate front...

The global cannabis industry has seen significant activity in the past 48 hours, led by market movement, evolving consumer trends, and regulatory challenges. Publicly traded cannabis stocks such as Tilray Brands, Canopy Growth, and Aurora Cannabis experienced high trading volumes this week, reflecting ongoing volatility and cautious investor optimism. These companies remain the top cannabis stocks to watch due to their international reach and diverse product portfolios, but analysts are not strongly bullish given persistent regulatory and financial headwinds. Current volatility mirrors previous months, though trading volumes have grown as investors anticipate regulatory movement and year-end results.

On the...

The cannabis industry over the past 48 hours has seen notable developments reflecting rapid mainstreaming, significant legal battles, and continued innovation. Major retailers are accelerating the integration of cannabis-related products into the consumer market. Circle K announced a groundbreaking partnership, planning to sell hemp-derived THC beverages at up to three thousand stores nationwide, beginning with launches in the Carolinas and Florida in late 2025. This move, in partnership with Horticulture Co. and NBA star Allen Iverson, marks the largest mainstream rollout to date and follows similar moves by Target and Total Wine, signaling a consumer shift toward hemp beverages and away from...

In the past 48 hours, the global cannabis industry has faced rapid change, driven by new partnerships, regulatory crackdowns, shifting consumer trends, and a steady—but cautious—investment environment. In the US, Circle K, a major convenience chain, announced plans to roll out hemp-derived THC beverages to as many as 3,000 stores nationwide starting in Q4 2025. This move, in partnership with Horticulture Co. and the Iverson brand, signals growing mainstream acceptance and could make cannabis beverages the most accessible cannabis product on the market to date[2].

Meanwhile, THC-infused drinks are both booming and under fire. National sales are projected to reac...

Over the past 48 hours, the cannabis industry has seen notable market activity, regulatory developments, and strategic business moves. Cannabis companies have petitioned the U.S. Supreme Court to block federal prohibition enforcement against state-legal cannabis operations, an action with potential long-term impact on industry growth and stability. Meanwhile, Congress is debating new hemp regulations, and state attorneys general are advocating the removal of intoxicating THC products, signifying increased scrutiny at both federal and state levels. In Texas and Kentucky, regulatory expansions have increased medical cannabis access, with Kentucky reporting 15,000 registered medical cannabis patients and full approval for its cannabis supply...

The cannabis industry has seen significant developments in the past 48 hours, highlighting intense market activity, regulatory changes, and industry innovation. California’s Unified Cannabis Enforcement Task Force seized and eradicated over 66.5 tons of illegal cannabis valued above 222 million dollars between July and September 2025, a clear sign of increased enforcement to support the legal market and reduce unregulated competition. This level of enforcement is one of the largest quarterly actions in the state's legal cannabis era and reflects ongoing pressures from illicit supply channels and fluctuating wholesale prices compared to last year’s stabilization period 1.

On the corporate side, Raw...

Over the past 48 hours, the global legal cannabis industry remains on a rapid growth trajectory, with the market projected to reach nearly $250 billion by 2033, expanding at a compound annual growth rate of 25.2% from 2025 to

For great deals today, check out https://amzn.to/44ci4hQ

This content was created in partnership and with the help of Artificial Intelligence AI

Over the past 48 hours, the cannabis industry has seen several significant changes that reflect its maturing status and growing mainstream acceptance. Major retail developments include Target launching a pilot program to sell THC-infused beverages in a select number of Minnesota stores. This move signals increasing retail acceptance of hemp-derived THC products and highlights the importance of proper regulatory frameworks. Executives from brands involved in the rollout have described Target’s decision as a milestone for the industry, while industry sentiment favors more robust regulations such as clear age restrictions and product testing requirements, aiming for a regulatory model similar to th...

The cannabis industry has undergone significant developments in the past 48 hours, highlighting resilience and adaptation amid ongoing challenges. The global legal marijuana market is now valued at approximately 22.5 billion dollars in 2024. It is projected to surge to 86.3 billion dollars by 2033, expanding at a robust annual growth rate of 16.1 percent, fueled by expanding legalization in key markets such as the United States, Canada, Europe, and Latin America. The medical segment accounts for over 83 percent of current revenue, with cannabis oils and tinctures leading product sales due to increased patient demand for precise dosing and therapeutic applications.

Recent deals and...

The cannabis industry is experiencing accelerated expansion and persistent volatility as of mid-October 2025. U.S. legal cannabis sales hit a record 2.34 billion dollars in September, up from 2.27 billion in August, pushing this year’s total to around 20 billion from 22 recreational markets, with Minnesota set to join soon. National projections estimate over 35 billion dollars in annual sales for 2025 with expectations to reach 70 billion by 2030 if federal reforms progress.

Market sentiment has been buoyed in the past week by renewed Congressional discussions about cannabis rescheduling and a recommendation by the Department of Health and Human Services to reclassify cannabis, which sp...

Cannabis Industry Update: October 9-10, 2025

The cannabis industry is experiencing significant regulatory turbulence and market expansion in recent days. On October 9, Texas Governor Greg Abbott directed the Department of Public Safety to increase enforcement against hemp product violations through undercover operations, while Ohio Governor Mike DeWine signed an executive order banning intoxicating hemp products for 90 days. These actions come as the U.S. Hemp Roundtable urged President Trump to prevent Congress from recriminalizing products containing any THC amount, warning this would reverse the hemp legalization he signed in 2018.

On the licensing front, Nebraska's Medical Cannabis Commission...

In the past 48 hours, the cannabis industry has experienced notable developments amid ongoing regulatory uncertainty and market volatility. First, the recent partnership between JP Brand Advisors and Canopy USA, announced on October 7, 2025, aims to rapidly expand national distribution of Wana Wellness hemp beverages and gummies. This venture targets the growing demand for non-alcoholic, functional hemp-infused drinks, capitalizing on rising consumer interest and retailer buy-in as regulatory clarity progresses in key states.

Meanwhile, U.S. multistate operators—like Trulieve Cannabis, Cresco Labs, and Verano Holdings—remain industry pillars, continuing strategic expansion in regulated markets. Analysts project the legal U.S. m...

The cannabis industry experienced significant developments in the past 48 hours, with regulatory momentum and corporate expansions dominating headlines.

MMJ International Holdings emerged as a key player positioning itself for the anticipated federal marijuana rescheduling from Schedule I to Schedule III. The company announced it has established exclusive agreements with international pharmaceutical-grade cannabis producers and secured distribution partnerships across European pharmacies. CEO Duane Boise stated that MMJ has two active FDA filings and GMP-certified laboratory infrastructure, differentiating the company from competitors focused on state-level dispensary operations. The company is targeting neurological conditions including Huntington's disease and Multiple Sclerosis with...

Over the past week, the cannabis industry has shown both continued growth and significant regulatory activity, particularly in the United States. The global cannabis cultivation market remains on a rapid expansion trajectory, with projections indicating it will grow from about $1.1 billion in 2024 to nearly $5 billion by 2034, reflecting a compound annual growth rate of 16.5%[4]. North America continues to lead this growth, but Europe and parts of Asia are quickly evolving as well, driven by progressive legislation and increased investment in medical cannabis.

In the U.S., California has once again been at the center of regulatory change. Governor Gavin...

The U.S. cannabis sector saw notable developments within the past 48 hours as regulatory and market changes continue to reshape the industry. This week, California paused a planned cannabis tax increase, offering some immediate relief to operators facing margin pressure, while in Illinois and Pennsylvania, state lawmakers and courts moved toward clearer hemp and medical cannabis regulations. Illinois lawmakers are near consensus on new rules to restrict youth access and improve public health protections, and Pennsylvania’s Supreme Court upheld stricter product testing, potentially impacting costs and quality assurance for medical producers.

At the federal level, Senator Rand Pa...

The global legal cannabis market is undergoing accelerated growth, reaching a valuation of 38.7 billion dollars in 2025 and projected to soar to over 141 billion dollars by 2032. Throughout the past week, this expansion has been driven by ongoing legalization, rising consumer acceptance, and growing demand for both medical and wellness cannabis products. North America remains dominant, with nearly 68 percent of worldwide revenues, thanks to robust regulatory frameworks in the United States and Canada. Europe is emerging as the fastest-growing region after Germany’s recent legalization of recreational marijuana.

In recent trading, key industry stocks such as Tilray Brands, Canopy Growth, an...

The cannabis industry is experiencing significant transformation over the past 48 hours, shaped by regulatory changes, major acquisitions, new product launches, and continued shifts in consumer behavior.

A major regulatory change just emerged in California, where Governor Gavin Newsom signed a law rolling back cannabis taxes from 25 percent back to 15 percent, effective next month through 2028. This strategic move aims to help legal businesses compete with the illicit market, which currently accounts for 60 percent of cannabis sales in the state. Last year, legal cannabis tax revenue in California fell below five billion dollars, nearly a billion less than in 2021, indicating...

In the past 48 hours, the cannabis industry has seen significant movement reflecting both accelerated growth and persistent headwinds. One of the most notable developments is the nationwide expansion of Edibles.com, a major e-commerce marketplace for hemp-derived THC products. As of September 18, Edible Brands now reaches over 65 percent of the U.S. market and offers same-day local delivery in several large states. This push represents not only increased access and convenience for consumers but also underscores growing mainstream acceptance of cannabis-infused wellness products. The company’s alignment with top chew brands like Wana, Wyld, and Kiva Confections points to edibles as...

The cannabis industry has seen significant developments in the past 48 hours, particularly in the United States, where expansion and consolidation have defined recent activity. In Minnesota, the Office of Cannabis Management announced a rapid rollout of adult-use cannabis sales. Since June 18, the state has issued 37 business licenses, 23 of which are to microbusinesses aiming for retail sales. The state's partnership with Tribal Nations such as the White Earth Nation and Mille Lacs Band of Ojibwe is creating new supply chain opportunities, with the first sale of tribally grown cannabis flower from a state-licensed business occurring September 16. Medical cannabis dispensaries are now...

The cannabis industry has experienced notable developments in the past 48 hours, marked by strong sales growth, regulatory maneuvering, new partnerships, and intensifying competition. In New York, the legal market posted robust sales numbers: total sales reached approximately 115.64 million dollars in April 2025, up from 109.38 million dollars in March, which is a year-over-year increase of more than 130 percent. Despite falling average item prices, the industry’s growth in sales and units underscores resilient consumer demand and highlights a maturing market environment. Over 5,250 licenses have now been approved in the state, with more than half issued to social and economic equity businesses. There ar...

In the past 48 hours, the global cannabis industry has shown remarkable dynamism, marked by robust market growth, major partnerships, volatile stock activity, new product launches, and regulatory shifts. New York’s legal cannabis retail market reached a milestone, surpassing $2.09 billion in total sales, with over $1 billion recorded in 2025 alone, reflecting accelerated consumer adoption and industry maturity over last year’s figures. The New York Cannabis Control Board also approved 46 new adult-use licenses, with 69 percent awarded to social and economic equity applicants, signaling an ongoing commitment to inclusivity and local participation.

In Canada, a new distribution agreement between XRPure and...

In the past 48 hours, the cannabis industry has navigated a complex landscape marked by cautious sentiment, operational innovation, and the continued quest for regulatory reform. According to a just-released poll of U.S. marijuana business leaders, optimism around federal rescheduling in 2025 remains low, with an average expectation of only 34 out of 100 that it will happen this year. Despite this, 97 percent of leaders said such reforms and the resulting tax relief are crucial for their long-term viability, underscoring the continued impact of the federal tax burden and the challenge of accessing traditional financial services. More than 80 percent of surveyed businesses that...